A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera

Running, not enrolling · Phase 3 · Has a placebo group

Conditions studied: Polycythemia Vera

In brief

The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV.

Key facts

Study ID
NCT05210790
Run by
Protagonist Therapeutics, Inc.
People needed
293
Starts
2022-04-01
Expected to finish
2027-06-01
Last updated by the study team
2025-08-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.